hydroxyproline has been researched along with candesartan in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frohlich, ED; Susic, D; Varagic, J | 1 |
| Ando, T; Itoh, M; Joh, T; Kuno, A; Masuda, K; Nakamura, S; Nakazawa, T; Nomura, T; Ogawa, K; Ohara, H; Sano, H; Sogawa, M; Yamada, T | 1 |
| Ando, T; Itoh, M; Joh, T; Kuno, A; Masuda, K; Nakamura, S; Nomura, T; Ogawa, K; Ohara, H; Okamoto, T; Shirai, T; Tang, M; Yamada, T | 1 |
| Fukui, H; Ikenaka, Y; Kitade, M; Kuriyama, S; Namisaki, T; Noguchi, R; Tsujinoue, H; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
| Koda, M; Matsunaga, Y; Murawaki, Y; Ueki, M; Yamamoto, S | 1 |
| Eskild-Jensen, A; Frøkiaer, J; Nyengaard, JR; Olesen, P; Paulsen, LF; Pedersen, L; Wogensen, L | 1 |
| Idikio, H; Jugdutt, BI; Uwiera, RR | 1 |
| Anderson, G; Baumann, M; Heemann, U; Hermans, R; Lutz, J; Schmaderer, C; Xing, CJ | 1 |
8 other study(ies) available for hydroxyproline and candesartan
| Article | Year |
|---|---|
Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: interaction with angiotensin type 2 receptors.
Topics: Angiotensin Receptor Antagonists; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Coronary Circulation; Heart Rate; Heart Ventricles; Hemodynamics; Hydroxyproline; Hypertension; Imidazoles; Male; Organ Size; Pyridines; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vascular Resistance | 2001 |
Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats.
Topics: Actins; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Body Weight; Fibrosis; Hydroxyproline; Immunohistochemistry; Inflammation; Male; Muscle, Smooth; Organ Size; Pancreatitis; Peroxidase; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 2003 |
Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats.
Topics: Actins; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Body Weight; Chronic Disease; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Fibrosis; Genes, ras; Hydroxyproline; Immunohistochemistry; Lisinopril; Male; Organ Size; Pancreatitis; Peptidyl-Dipeptidase A; Peroxidase; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles | 2005 |
Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Cell Proliferation; Collagen Type I; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hydroxyproline; Interferon-beta; Kupffer Cells; Liver; Liver Cirrhosis, Experimental; Male; Mice; Mice, Inbred BALB C; Perindopril; Rats; Rats, Inbred F344; RNA, Messenger; Tetrazoles | 2005 |
Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Common Bile Duct; Connective Tissue Growth Factor; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Gene Expression; Hydroxyproline; Immediate-Early Proteins; Insulin-Like Growth Factor Binding Proteins; Intercellular Signaling Peptides and Proteins; Ligation; Liver; Liver Cirrhosis, Experimental; Male; Polymerase Chain Reaction; Rats; Rats, Wistar; RNA; Tetrazoles; Transforming Growth Factor beta1; Treatment Outcome | 2006 |
AT1 receptor blockade prevents interstitial and glomerular apoptosis but not fibrosis in pigs with neonatal induced partial unilateral ureteral obstruction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Apoptosis; Benzimidazoles; Biphenyl Compounds; Capillaries; Caspase 3; Cell Count; Collagen; Female; Fibrosis; Hydroxyproline; Immunohistochemistry; Kidney Glomerulus; Kidney Tubules; Nephritis, Interstitial; Swine; Tetrazoles; Tissue Fixation; Ureteral Obstruction | 2007 |
Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Dogs; Enalapril; Hydroxyproline; Myocardial Infarction; Myocardial Reperfusion; Peptidyl-Dipeptidase A; Tetrazoles; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Remodeling; Wound Healing | 2007 |
AGE formation blockade with aminoguanidine does not ameliorate chronic allograft nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cardiotonic Agents; Dinoprost; Enzyme Inhibitors; Glycation End Products, Advanced; Guanidines; Hydroxyproline; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Lysine; Male; Oxidative Stress; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Tetrazoles; Time Factors; Transplantation, Homologous | 2011 |